Novozymes A/S
LSE:0Q4U
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novozymes A/S
LSE:0Q4U
|
DK |
|
Danimer Scientific Inc
OTC:DNMR
|
US |
|
Danimer Scientific Inc
OTC:DNMRQ
|
US |
|
A
|
Autozone Inc
LSE:0HJL
|
US |
|
Chimera Investment Corp
LSE:0A7B
|
US |
Wall St Price Targets
0Q4U Price Targets Summary
Novozymes A/S
According to Wall Street analysts, the average 1-year price target for 0Q4U is 478.94 DKK with a low forecast of 387.71 DKK and a high forecast of 585.5 DKK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0Q4U's stock price target?
Price Target
478.94
DKK
According to Wall Street analysts, the average 1-year price target for 0Q4U is 478.94 DKK with a low forecast of 387.71 DKK and a high forecast of 585.5 DKK.
What is the Revenue forecast for Novozymes A/S?
Projected CAGR
-55%
Over the last 7 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 2 years is -55%.
What is the Net Income forecast for Novozymes A/S?
Projected CAGR
-56%
Over the last 7 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 2 years is -56%.
